Richard Peter Marshall insider trades: Serina Therapeutics (SER) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | SER | ↑ Buy | 12,183 | $1.65 | $20K | Direct | May 22, 2026 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SER insiders
Open-market trades in the last 12 months
About Richard Peter Marshall's insider trades
Richard Peter Marshall is a director at Serina Therapeutics (SER). Since May 19, 2026, Richard has reported 1 open-market purchase worth $20K and no sales on SEC Form 4. In the last 12 months: 1 buy ($20K).
Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SER insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.